This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Steen VD, Medsger TA. Epidemiology and natural history of systemic sclerosis. Rheum Dis Clin North Am. 1990; 16(1):1-10.SteenVDMedsgerTA.Epidemiology and natural history of systemic sclerosis. Rheum Dis Clin North Am. 1990; 16(1):110.Search in Google Scholar
Medsger TA Jr. Epidemiology of systemic sclerosis. Clin Dermatol. 1994; 12(2):207-216.MedsgerTAJr.Epidemiology of systemic sclerosis. Clin Dermatol. 1994; 12(2):207216.Search in Google Scholar
Scussel-Lonzetti L, Joyal F, Raynauld JP, et al. Predicting mortality in systemic sclerosis: Analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore). 2002; 81(2):154-67.Scussel-LonzettiLJoyalFRaynauldJPPredicting mortality in systemic sclerosis: Analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore). 2002; 81(2):15467.Search in Google Scholar
Shand L, Lunt M, Nihtyanova S, et al. Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: Application of a latent linear trajectory model. Arthritis Rheum. 2007; 56(7):2422-2431.ShandLLuntMNihtyanovaSRelationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: Application of a latent linear trajectory model. Arthritis Rheum. 2007; 56(7):24222431.Search in Google Scholar
Burchfield C, Vorrasi J. Maxillofacial Implications of Scleroderma and Systemic Sclerosis: A Case Report and Literature Review. J Oral Maxillofac Surg. 2019;77(6):1203-1208.BurchfieldCVorrasiJ.Maxillofacial Implications of Scleroderma and Systemic Sclerosis: A Case Report and Literature Review. J Oral Maxillofac Surg. 2019;77(6):1203-1208.Search in Google Scholar
Sozeri B, Gulez N, Aksu G, et al. Pesticide-induced scleroderma and early intensive immunosuppressive treatment. Arch Environ Occup Health. 2012; 67(1):43-47.SozeriBGulezNAksuGPesticide-induced scleroderma and early intensive immunosuppressive treatment. Arch Environ Occup Health. 2012; 67(1):4347.Search in Google Scholar
Pollard KM, Pearson DL, Hultman P, et al. Lupus-prone mice as models to study xenobiotic-induced acceleration of systemic autoimmunity. Environ Health Perspect. 1999; 107(Suppl 5):729–735.PollardKMPearsonDLHultmanPLupus-prone mice as models to study xenobiotic-induced acceleration of systemic autoimmunity. Environ Health Perspect. 1999; 107(Suppl 5):729–735.Search in Google Scholar
Wynn TA. Fibrotic disease and the T (H) 1 / T (H) 2 paradigm. Nat Rev Immunol. 2004; 4(8):583–594.WynnTA.Fibrotic disease and the T (H) 1 / T (H) 2 paradigm. Nat Rev Immunol. 2004; 4(8):583–594.Search in Google Scholar
Granel B, Chevillard C, Allanore Y, et al. Evaluation of interleukin 13 polymorphisms in systemic sclerosis. Immunogenetics. 2006;58(8):693–699.GranelBChevillardCAllanoreYEvaluation of interleukin 13 polymorphisms in systemic sclerosis. Immunogenetics. 2006;58(8):693–699.Search in Google Scholar
Matsushita T, Hasegawa M, Hamaguchi Y, et al. Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis. J Rheumatol. 2006; 33(2):275–284.MatsushitaTHasegawaMHamaguchiYLongitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis. J Rheumatol. 2006; 33(2):275–284.Search in Google Scholar
Mavalia C, Scaletti C, Romagnani P, et al. Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis. Am J Pathol. 1997; 151(6):1751–1758.MavaliaCScalettiCRomagnaniPType 2 helper T-cell predominance and high CD30 expression in systemic sclerosis. Am J Pathol. 1997; 151(6):1751–1758.Search in Google Scholar
Hoffmann SC, Stanley EM, Darrin Cox E, et al. Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimu-lated peripheral blood lymphocytes. Transplantation. 2001;72(8):1444–1450.HoffmannSCStanleyEMDarrin CoxEAssociation of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimu-lated peripheral blood lymphocytes. Transplantation. 2001;72(8):1444–1450.Search in Google Scholar
Suarez A, Castro P, Alonso R, et al. Inter-individual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms. Transplantation. 2003;75(5):711–717.SuarezACastroPAlonsoRInter-individual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms. Transplantation. 2003;75(5):711–717.Search in Google Scholar
Xu D, Mu R, Wei X. The Roles of IL-1 Family Cytokines in the Pathogenesis of Systemic Sclerosis. Front Immunol. 2019;10:2025.XuDMuRWeiX.The Roles of IL-1 Family Cytokines in the Pathogenesis of Systemic Sclerosis. Front Immunol. 2019;10:2025.Search in Google Scholar
Hutyrova B, Lukac J, Bosak V, et al. Interleukin 1_ single nucleotide polymorphism associated with systemic sclerosis. J Rheumatol. 2004;31(1):81–84.HutyrovaBLukacJBosakVInterleukin 1_ single nucleotide polymorphism associated with systemic sclerosis. J Rheumatol. 2004;31(1):81–84.Search in Google Scholar
Beretta L, Bertolotti F, Cappiello F, et al. Interleukin-1 gene complex polymorphisms in systemic sclerosis patients with severe restrictive lung physiology. Hum Immunol. 2007a; 68(7):603–609.BerettaLBertolottiFCappielloFInterleukin-1 gene complex polymorphisms in systemic sclerosis patients with severe restrictive lung physiology. Hum Immunol. 2007a; 68(7):603–609.Search in Google Scholar
Mattuzzi S, Barbi S, Carletto A, et al. Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis. J Rheumatol. 2007; 34(5):997–1004.MattuzziSBarbiSCarlettoAAssociation of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis. J Rheumatol. 2007; 34(5):997–1004.Search in Google Scholar
Crilly A, Hamilton J, Clark CJ, et al. Analysis of the 5’ flanking region of the interleukin 10 gene in patients with systemic sclerosis. Rheumatology (Oxford). 2003;42(11):1295–1298.CrillyAHamiltonJClarkCJAnalysis of the 5’ flanking region of the interleukin 10 gene in patients with systemic sclerosis. Rheumatology (Oxford). 2003;42(11):1295–1298.Search in Google Scholar
Beretta L, Cappiello F, Barili M, et al. Proximal interleukin-10 gene polymorphisms in Italian patients with systemic sclerosis. Tissue Antigens. 2007b; 69(4):305–312.BerettaLCappielloFBariliMProximal interleukin-10 gene polymorphisms in Italian patients with systemic sclerosis. Tissue Antigens. 2007b; 69(4):305–312.Search in Google Scholar
Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma) Arthritis Rheum. 1980;23:581–90.Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma) Arthritis Rheum. 1980;23:581–90.Search in Google Scholar
Katsumoto TR, Whitfield ML, Connolly MK. The pathogenesis of systemic sclerosis. Ann Rev Pathol. 2011; 6:509-537.KatsumotoTRWhitfieldMLConnollyMK.The pathogenesis of systemic sclerosis. Ann Rev Pathol. 2011; 6:509-537.Search in Google Scholar
Hurme M, Lahdenpohja N, Santtila S. Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases. Ann Med. 1998; 30(5):469-473.HurmeMLahdenpohjaNSanttilaS.Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases. Ann Med. 1998; 30(5):469473.Search in Google Scholar
Hwang IR, Kodama T, Kikuchi S, et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology. 2002;123(6):1793-1803.HwangIRKodamaTKikuchiSEffect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology. 2002;123(6):1793-1803.Search in Google Scholar
Iacoviello L, Di Castelnuovo A, Gattone M, et al. Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol. 2005;25(1):222-227.IacovielloLDi CastelnuovoAGattoneMPolymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol. 2005;25(1):222-227.Search in Google Scholar
Wen AQ, Gu W, Wang J, et al. Clinical relevance of IL-1β promoter polymorphisms (-1470,-511, and-31) in patients with major trauma. Shock. 2010; 33(6):576–582.WenAQGuWWangJClinical relevance of IL-1β promoter polymorphisms (-1470,-511, and-31) in patients with major trauma. Shock. 2010; 33(6):576–582.Search in Google Scholar
Yin WT, Pan YP, Lin L. Association between IL-1α rs17561 and IL-1β rs1143634 polymorphisms and periodontitis: a meta-analysis. Genet Mol Res. 2016;15(1).YinWTPanYPLinL.Association between IL-1α rs17561 and IL-1β rs1143634 polymorphisms and periodontitis: a meta-analysis. Genet Mol Res. 2016;15(1).Search in Google Scholar
Lavu V, Venkatesan V, Venugopal P, et al. Clinical Relevance of Cytokines Gene Polymorphisms and Protein Levels in Gingival Cervical Fluid from Chronic Periodontitis Patients. Iran J Immunol. 2017;14(1):51-58.LavuVVenkatesanVVenugopalPClinical Relevance of Cytokines Gene Polymorphisms and Protein Levels in Gingival Cervical Fluid from Chronic Periodontitis Patients. Iran J Immunol. 2017;14(1):51-58.Search in Google Scholar
Jagadish R, Mehta DS, Jagadish P. Oral and periodontal manifestations associated with systemic sclerosis: a case series and review. J Indian Soc Periodontol. 2012;16(2):271–274.JagadishRMehtaDSJagadishP.Oral and periodontal manifestations associated with systemic sclerosis: a case series and review. J Indian Soc Periodontol. 2012;16(2):271–274.Search in Google Scholar
Grewal IS. Overview of TNF superfamily: a chest full of potential therapeutic targets. Adv Exp Med Biol. 2009;647:1-7.GrewalIS.Overview of TNF superfamily: a chest full of potential therapeutic targets. Adv Exp Med Biol. 2009;647:1-7.Search in Google Scholar
Kantor TV, Frieberg D, Medsger TA Jr, et al. Cytokine production and serum levels in systemic sclerosis. Clin Immunol Immunopathol. 1992;65(3):278-285.KantorTVFriebergDMedsger TAJrCytokine production and serum levels in systemic sclerosis. Clin Immunol Immunopathol. 1992;65(3):278-285.Search in Google Scholar
Young V, Ho M, Vosper H, et al. Elevated expression of the genes encoding TNF-alpha and thromboxane synthase in leukocytes from patients with systemic sclerosis. Rheumatology (Oxford). 2002; 41(8):869-875.YoungVHoMVosperHElevated expression of the genes encoding TNF-alpha and thromboxane synthase in leukocytes from patients with systemic sclerosis. Rheumatology (Oxford). 2002; 41(8):869875.Search in Google Scholar
Bolster MB, Ludwicka A, Sutherland SE, et al. Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis. Arthritis Rheum. 1997; 40(4):743-751.BolsterMBLudwickaASutherlandSECytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis. Arthritis Rheum. 1997; 40(4):743751.Search in Google Scholar
Mathai SK, Gulati M, Peng X, et al. Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. Lab Invest. 2010; 90(6):812-823.MathaiSKGulatiMPengXCirculating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. Lab Invest. 2010; 90(6):812823.Search in Google Scholar
Azab E, Elfasakhany FM. Effect of tumor necrosis factor alpha (TNF-α)-308 and-1031 gene polymorphisms on periodontitis among Saudi subjects. Saudi Dent J. 2022;34(3):226-231.AzabEElfasakhanyFM.Effect of tumor necrosis factor alpha (TNF-α)-308 and-1031 gene polymorphisms on periodontitis among Saudi subjects. Saudi Dent J. 2022;34(3):226-231.Search in Google Scholar
Huizinga TW, Westendorp RG, Bollen EL, et al. TNF-alpha promoter polymorphisms, production, and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol. 1997; 72(2):149–153.HuizingaTWWestendorpRGBollenELTNF-alpha promoter polymorphisms, production, and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol. 1997; 72(2):149–153.Search in Google Scholar
Tolusso B, Fabris M, Caporali R, et al.-238 and +489 TNF-alpha along with TNF-RII gene polymorphisms associate with the diffuse phenotype in patients with systemic sclerosis. Immunol Lett. 2005;96(1):103–108.TolussoBFabrisMCaporaliR-238 and +489 TNF-alpha along with TNF-RII gene polymorphisms associate with the diffuse phenotype in patients with systemic sclerosis. Immunol Lett. 2005;96(1):103–108.Search in Google Scholar
Perrey C, Pravica V, Sinnott PJ, et al. Genotyping for polymorphisms in interferon-γ, interleukin-10, transforming growth factor-β1 and tumor necrosis factor-α genes: a technical report. Transpl Immunol. 1998; 6(3):193–197.PerreyCPravicaVSinnottPJGenotyping for polymorphisms in interferon-γ, interleukin-10, transforming growth factor-β1 and tumor necrosis factor-α genes: a technical report. Transpl Immunol. 1998; 6(3):193–197.Search in Google Scholar
Saremi L, Shafizadeh M, Ghaffari ME, et al. Evaluation of interleukin 10, interleukin 1-beta, and tumor necrosis factor-alpha gene polymorphisms in patients with periodontitis and healthy controls. Egypt J Med Hum Genet. 2022;23:157.SaremiLShafizadehMGhaffariMEEvaluation of interleukin 10, interleukin 1-beta, and tumor necrosis factor-alpha gene polymorphisms in patients with periodontitis and healthy controls. Egypt J Med Hum Genet. 2022;23:157.Search in Google Scholar
Zhou Y, Gsicombe R, Huang D, et al. Novel genetic association of Wegener’s granulomatosis with the interleukin-10 gene. J Rheumatol. 2002; 29(2):317–320.ZhouYGsicombeRHuangDNovel genetic association of Wegener’s granulomatosis with the interleukin-10 gene. J Rheumatol. 2002; 29(2):317–320.Search in Google Scholar
Crilly A, Hamilton J, Clark CJ, et al. Analysis of transforming growth factor β1 gene polymorphisms in patients with systemic sclerosis. Ann Rheum Dis. 2002; 61(8):678–681.CrillyAHamiltonJClarkCJAnalysis of transforming growth factor β1 gene polymorphisms in patients with systemic sclerosis. Ann Rheum Dis. 2002; 61(8):678–681.Search in Google Scholar
Sugiura Y, Banno S, Matsumoto Y, et al. Transforming growth factor beta1 gene polymorphism in patients with systemic sclerosis. J Rheumatol. 2003; 30(7):1520–1523.SugiuraYBannoSMatsumotoYTransforming growth factor beta1 gene polymorphism in patients with systemic sclerosis. J Rheumatol. 2003; 30(7):1520–1523.Search in Google Scholar
Peoples C, Medsger TA Jr, Lucas M, et al. Gender differences in systemic sclerosis: relationship to clinical features, serologic status and outcomes. J Scleroderma Relat Disord. 2016;1(2):177-240.PeoplesCMedsgerTAJrLucasMGender differences in systemic sclerosis: relationship to clinical features, serologic status and outcomes. J Scleroderma Relat Disord. 2016;1(2):177-240.Search in Google Scholar